Ultrasensitive chimerism after allo-HCT to augment MRD data

09.26.23

Ultrasensitive chimerism after allo-HCT to augment MRD data

by ASTCT Science Highlights

High Concordance Seen Between MRD Measurement by MFC and FGT in Infants with KMT2A-r ALL

06.19.23

High Concordance Seen Between MRD Measurement by MFC and FGT in Infants with KMT2A-r ALL

by Eleanor Mayfield, ELS

NGS-MRD Panel Is “Highly Sensitive, Accurate” in AML

06.12.23

NGS-MRD Panel Is “Highly Sensitive, Accurate” in AML

by Eleanor Mayfield, ELS

Lenalidomide Maintenance and MRD 100 Days Post ASCT Predict PFS in Real-World Patient Cohort in Brazil

05.29.23

Lenalidomide Maintenance and MRD 100 Days Post ASCT Predict PFS in Real-World Patient Cohort in Brazil

by Eleanor Mayfield, ELS

Individualized Busulfan Dosing Improves Outcomes vs. Fixed Dosing in Pre-Transplant, MRD+, Intermediate-Risk AML Patients Receiving Allo-SCT

05.25.23

Individualized Busulfan Dosing Improves Outcomes vs. Fixed Dosing in Pre-Transplant, MRD+, Intermediate-Risk AML Patients Receiving Allo-SCT

by Eleanor Mayfield, ELS

Value of DNA sequencing pre-HCT for AML patients

05.09.23

Value of DNA sequencing pre-HCT for AML patients

by ASTCT Science Highlights

Pre-Transplant DNA Sequencing Suggests Association Between Persistence of Most-Common AML Variants and Poorer Outcomes in Patients with AML

05.08.23

Pre-Transplant DNA Sequencing Suggests Association Between Persistence of Most-Common AML Variants and Poorer Outcomes in Patients with AML

by Eleanor Mayfield, ELS

ddPCR, NGS “Are Promising Alternative Approaches to MRD Assessment in ALL”

04.19.23

ddPCR, NGS “Are Promising Alternative Approaches to MRD Assessment in ALL”

by Eleanor Mayfield, ELS

Nanopore-Based Monitoring of Cell-Free DNA “Possible Biomarker in B-ALL”

04.11.23

Nanopore-Based Monitoring of Cell-Free DNA “Possible Biomarker in B-ALL”

by Eleanor Mayfield, ELS

Theme picker